Caladrius Biosciences (CLBS) Short Interest Ratio & Short Volume

Short interest is the volume of Caladrius Biosciences shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 477,900 shares of CLBS short. 0.81% of Caladrius Biosciences' shares are currently sold short. Learn More on Caladrius Biosciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLBS shares currently have a short interest ratio of 3.0. Learn More on Caladrius Biosciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.81% of Caladrius Biosciences' floating shares are currently sold short.

Caladrius Biosciences saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 477,900 shares, a decline of 13.2% from the previous total of 550,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Caladrius Biosciences currently has issued a total of 60,583,000 shares. Some of Caladrius Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Caladrius Biosciences currently has a public float of 59,030,000 shares.

0.81% of Caladrius Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Caladrius Biosciences: Anixa Biosciences Inc (1.31%), Monogram Orthopaedics Inc. (2.02%), HilleVax, Inc. (7.11%), Prenetics Global Limited (0.38%), Milestone Pharmaceuticals Inc. (4.67%), MDxHealth SA (0.11%), Contineum Therapeutics, Inc. (5.73%), Jin Medical International Ltd. (1.19%), Tenaya Therapeutics, Inc. (8.86%), BeyondSpring Inc. (6.45%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Corporation ($4.91 billion), Charter Communications, Inc. ($3.53 billion), Suncor Energy Inc. ($2.26 billion), T. Rowe Price Group, Inc. ($2.01 billion), Chesapeake Energy Co. ($1.92 billion), Lucid Group, Inc. ($1.84 billion), Plug Power, Inc. ($1.81 billion), Williams-Sonoma, Inc. ($1.66 billion), Coinbase Global, Inc. ($1.64 billion), and Lumen Technologies, Inc. ($1.50 billion). View all of the most shorted stocks.

Short selling CLBS is an investing strategy that aims to generate trading profit from Caladrius Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Caladrius Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLBS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLBS, twice per month. The most recent reporting period available is August, 31 2022.